Details for New Drug Application (NDA): 217559
✉ Email this page to a colleague
The generic ingredient in THIOTEPA is thiotepa. There are eleven drug master file entries for this compound. Nine suppliers are listed for this compound. Additional details are available on the thiotepa profile page.
Medical Subject Heading (MeSH) Categories for 217559
Profile for product number 001
Active Rx/OTC/Discontinued: | RX | Dosage: | POWDER;INTRACAVITARY, INTRAVENOUS, INTRAVESICAL | Strength | 15MG/VIAL | ||||
Approval Date: | Aug 20, 2024 | TE: | AP | RLD: | No |
Complete Access Available with Subscription